Key result
Atypical antipsychotics were associated with significantly fewer symptoms of cognitive impairment and hostility/excitement (p < .05) than traditional antipsychotics, but not better work status.
Why the study?
Does atypical antipsychotic therapy improve work status compared to traditional antipsychotics in clients with schizophrenia-spectrum disorders in a psychiatric rehabilitation program?
Cross-Sectional (n=82)
Does atypical antipsychotic therapy improve work status compared to traditional antipsychotics in clients with schizophrenia-spectrum disorders in a psychiatric rehabilitation program?
p-value: p=<.05
Atypical antipsychotics were associated with better symptom control but not better work status compared to traditional antipsychotics in clients in a psychiatric rehabilitation program.
No takes yet. Share an insight, caveat, or question.
Atypical antipsychotics should not yet guide choices for work outcomes in schizophrenia; hypothesis-generating for symptom benefits in rehabilitation.
Meyer-Kalos et al. (2002) conducted a cross-sectional in DSM-IV schizophrenia-spectrum disorders (n=82). Atypical antipsychotics (olanzapine or risperidone) vs. Traditional antipsychotics was evaluated on Symptom and work status (p=<.05). Atypical antipsychotics were associated with significantly fewer symptoms of cognitive impairment and hostility/excitement (p < .05) than traditional antipsychotics, but not better work status.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: